首页 › 基金 › Nearwater Capital Markets, Ltd › NBIX
Nearwater Capital Markets, Ltd 对 NBIX 的持仓历史
NEUROCRINE BIOSCIENCES INC · 医疗保健
Nearwater Capital Markets, Ltd 在 Q3 2026 的 13F 申报中披露持有 NBIX(NEUROCRINE BIOSCIENCES INC)155,000 股,市值约 US$22.0M,约占其申报组合的 0.50%,在其申报持仓中市值排名第 46 位。 Nearwater Capital Markets, Ltd 最近 2 个申报季度中有 2 个季度披露了 NBIX 持仓,最早可追溯至 Q2 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Nearwater Capital Markets, Ltd 对 NBIX 的持仓演变
Nearwater Capital Markets, Ltd 于 Q2 2026 首次披露 NBIX 持仓:155,000 股(约 US$26.1M)。 在 2 次申报中,Nearwater Capital Markets, Ltd 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 155,000 股、市值约 US$22.0M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 155.00K | $26.12M | 新进 |
| Q3 2026 | 155.00K | $21.99M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NBIX 与 13F 数据
NBIX(NEUROCRINE BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 NBIX,申报仓位最大的包括:文艺复兴科技 (US$326.3M), Vestal Point Capital, LP (US$316.8M), RTW INVESTMENTS, LP (US$133.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NBIX 的基金
- 文艺复兴科技 2.30M 股 · $326.33M · Q3 2026
- Vestal Point Capital, LP 1.88M 股 · $316.85M · Q2 2026
- RTW INVESTMENTS, LP 942.68K 股 · $133.71M · Q3 2026
更多关于 Nearwater Capital Markets, Ltd
常见问题
How long has Nearwater Capital Markets, Ltd held NBIX?
Nearwater Capital Markets, Ltd has disclosed NBIX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Nearwater Capital Markets, Ltd's current position in NBIX?
As of Q3 2026, Nearwater Capital Markets, Ltd holds 155.00K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $21.99M, representing 0.50% of its reported portfolio and ranking #46.
Has Nearwater Capital Markets, Ltd been buying or selling NBIX?
In the latest 13F filing (Q3 2026), Nearwater Capital Markets, Ltd held unchanged its position in NBIX.
Which other funds hold NBIX?
Other major institutional holders of NBIX include 文艺复兴科技, Vestal Point Capital, LP, RTW INVESTMENTS, LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.